CLINICAL_TRIALS trial_result · 2026-08-07

Clinical Trial Results: A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD) [Phase 1]

First-in-human Phase 1 trial results for IBC-Ab002 in individuals with early Alzheimer's disease have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Immunobrain Checkpoint | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2026-08-07